Search research articles
Contact Us
Filters
Showing results (11-20 of 287) with videos related to
Page
of 29
Sort By:
Brain Pathology (Zurich, Switzerland)
|
October 12, 1999
Alpha-synuclein in Lewy body disease and Alzheimer's disease
M Hashimoto, E Masliah
Methods in Molecular Medicine
|
March 8, 2011
Assays for the analysis of synaptic proteins in neurodegenerative disorders
E Masliah, M Alford
Brain Pathology (Zurich, Switzerland)
|
January 1, 1993
The role of synaptic proteins in the pathogenesis of disorders of the central nervous system
E Masliah, R Terry
Journal of Neuropathology and Experimental Neurology
|
April 10, 1999
Evidence for neuroprotective effects of acidic fibroblast growth factor in Alzheimer disease
V Thorns, E Masliah
Neuroscience
|
May 21, 1999
Synaptic alterations in apolipoprotein E knockout mice
I Veinbergs, E Masliah
Journal of Neural Transmission. Supplementum
|
August 29, 2000
Genetically altered transgenic models of Alzheimer's disease
E Masliah, E Rockenstein
Drugs of Today (Barcelona, Spain : 1998)
|
April 20, 2012
The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders
E Masliah, E Díez-Tejedor
Clinical Neuropathology
|
November 1, 1993
Atypical diffuse Lewy body disease with neuritic abnormalities
E Reyes, A Gamboa, E Masliah
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
October 23, 2001
Locally reduced levels of acidic FGF lead to decreased expression of 28-kda calbindin and contribute to the selective vulnerability of the neurons in the entorhinal cortex in Alzheimer's disease
V Thorns, F Licastro, E Masliah
Experimental Neurology
|
March 26, 1998
nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease
V Thorns, L Hansen, E Masliah
Page
of 29
Search research articles
Search
Showing results (11-20 of 287) with videos related to
Sort By:
Page
of 29
Brain Pathology (Zurich, Switzerland)
|
October 12, 1999
Alpha-synuclein in Lewy body disease and Alzheimer's disease
M Hashimoto, E Masliah
Methods in Molecular Medicine
|
March 8, 2011
Assays for the analysis of synaptic proteins in neurodegenerative disorders
E Masliah, M Alford
Brain Pathology (Zurich, Switzerland)
|
January 1, 1993
The role of synaptic proteins in the pathogenesis of disorders of the central nervous system
E Masliah, R Terry
Journal of Neuropathology and Experimental Neurology
|
April 10, 1999
Evidence for neuroprotective effects of acidic fibroblast growth factor in Alzheimer disease
V Thorns, E Masliah
Neuroscience
|
May 21, 1999
Synaptic alterations in apolipoprotein E knockout mice
I Veinbergs, E Masliah
Journal of Neural Transmission. Supplementum
|
August 29, 2000
Genetically altered transgenic models of Alzheimer's disease
E Masliah, E Rockenstein
Drugs of Today (Barcelona, Spain : 1998)
|
April 20, 2012
The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders
E Masliah, E Díez-Tejedor
Clinical Neuropathology
|
November 1, 1993
Atypical diffuse Lewy body disease with neuritic abnormalities
E Reyes, A Gamboa, E Masliah
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
October 23, 2001
Locally reduced levels of acidic FGF lead to decreased expression of 28-kda calbindin and contribute to the selective vulnerability of the neurons in the entorhinal cortex in Alzheimer's disease
V Thorns, F Licastro, E Masliah
Experimental Neurology
|
March 26, 1998
nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease
V Thorns, L Hansen, E Masliah
Page
of 29